ScienceDex / Researcher record
Ahmad, Saira
- Eldec Pharmaceuticals, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2022 | $999,919 | 1 | #9,835 |
| 2023 | $1,331,628 | 3 | #6,933 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20221 record
- FY2023 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Ahmad, Saira as a PI. Multi-PI records show the full award amount for context.
- 5R44HL165964-02R44Contact PINovel Strategies to Clear Bacteria from the CF Lung$977.8Kaward amount
- 1R43AI174395-01R43Contact PINovel Peptide Immunomodulators for Treating Sepsis$259.1Kaward amount
- 3R44HL165964-01S1R44Contact PINovel Strategies to Clear Bacteria from the CF Lung$94.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Ahmad, Saira as a PI.
FY2023 award administered by Eldec Pharmaceuticals, Inc. (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardEldec Pharmaceuticals, Inc.
- 2022$500K Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9835
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding